A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Alector, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 561,750 shares of ALEC stock, worth $1.04 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
561,750
Previous 655,050 14.24%
Holding current value
$1.04 Million
Previous $2.97 Million 11.77%
% of portfolio
0.0%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$4.34 - $6.58 $404,922 - $613,914
-93,300 Reduced 14.24%
561,750 $2.62 Million
Q2 2024

Aug 09, 2024

SELL
$4.19 - $6.23 $85,614 - $127,297
-20,433 Reduced 3.02%
655,050 $2.97 Million
Q1 2024

May 13, 2024

BUY
$5.69 - $8.08 $588,915 - $836,280
103,500 Added 18.09%
675,483 $4.07 Million
Q4 2023

Feb 13, 2024

BUY
$3.77 - $8.39 $263,070 - $585,454
69,780 Added 13.89%
571,983 $4.56 Million
Q3 2023

Nov 14, 2023

SELL
$5.2 - $8.77 $961,376 - $1.62 Million
-184,880 Reduced 26.91%
502,203 $3.25 Million
Q2 2023

Aug 11, 2023

BUY
$5.86 - $7.93 $217,534 - $294,377
37,122 Added 5.71%
687,083 $4.13 Million
Q1 2023

May 12, 2023

BUY
$5.85 - $9.84 $340,171 - $572,186
58,149 Added 9.83%
649,961 $4.02 Million
Q4 2022

Feb 13, 2023

SELL
$6.88 - $9.55 $885,944 - $1.23 Million
-128,771 Reduced 17.87%
591,812 $5.46 Million
Q3 2022

Nov 14, 2022

SELL
$8.19 - $13.2 $2.01 Million - $3.25 Million
-246,000 Reduced 25.45%
720,583 $6.82 Million
Q2 2022

Aug 12, 2022

BUY
$7.65 - $14.24 $2 Million - $3.71 Million
260,803 Added 36.95%
966,583 $9.82 Million
Q1 2022

May 13, 2022

BUY
$13.02 - $20.78 $5.63 Million - $8.98 Million
432,300 Added 158.07%
705,780 $10.1 Million
Q4 2021

Feb 11, 2022

BUY
$19.35 - $25.54 $5.29 Million - $6.98 Million
273,480 New
273,480 $5.65 Million
Q3 2020

Nov 13, 2020

SELL
$10.54 - $24.96 $735,481 - $1.74 Million
-69,780 Closed
0 $0
Q2 2020

Aug 13, 2020

BUY
$21.87 - $33.11 $1.53 Million - $2.31 Million
69,780 New
69,780 $1.71 Million

Others Institutions Holding ALEC

About Alector, Inc.


  • Ticker ALEC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,563,904
  • Market Cap $153M
  • Description
  • Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...
More about ALEC
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.